The distribution of structural neuropathology in pre-clinical Huntington's disease

Brain

Volumn 125, Issue 8, 2002, Pages 1815-1828

  Thieben, M J ^a   Duggins, A J ^a,c   Good, C D ^c   Gomes, L ^a   Mahant, N ^a   Richards, F ^b   McCusker, E ^a   Frackowiak, R S J ^c  

^a WESTMEAD HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Asymmetry; Huntington's disease; MRI; Striatum; VBM

Indexed keywords

NEUROPROTECTIVE AGENT;

ADULT; AGE; ARTICLE; BRAIN ATROPHY; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; DRUG EFFICACY; FEMALE; GENE MUTATION; GENOTYPE; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; INSULA; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MORPHOMETRICS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STRIATE CORTEX; STRUCTURE ANALYSIS; WHITE MATTER;

EID: 0036345704     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf179     Document Type: Article

References (79)

1. The functional anatomy of basal ganglia disorders
2. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic huntington's disease: An in situ hybridization study
3. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
4. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain
5. Voxel-based morphometry-the methods
6. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons
7. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease
8. Longitudinal change in basal ganglia volume in patients with Huntington's disease
9. Frontal lobe volume in patients with Huntington's disease
10. Dissociation of working memory from decision making within the human prefrontal cortex
11. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
12. Decreased striatal monoaminergic terminals in Huntington disease
13. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size
14. Cellular factors controlling neuronal vulnerability in the brain: A lesson from the striatum
15. Impaired recognition and experience of disgust following brain injury
16. Impulsive choice induced in rats by lesions of the nucleus accumbens core
17. A one-hit model of cell death in inherited neuronal degenerations
18. A comparison of frontoparietal fMRI activation during anti-saccades and anti-pointing
19. Frontoparietal cortical networks for directing attention and the eye to visual locations: Identical, independent, or overlapping neural systems?
20. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the Huntington disease mutation
21. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease
22. Autonomic nervous function in Huntington's disease
23. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
24. Trinucleotide repeat length instability and age of onset in Huntington's disease
25. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers
26. Quantitative neuropathological changes in presymptomatic Huntington's disease
27. A voxel-based morphometric study of ageing in 465 normal adult human brains
28. Cerebral asymmetry and the effects of sex and handedness on brain structure: A voxel-based morphometric analysis of 465 normal adult human brains
29. Impaired recognition of disgust in Huntington's disease gene carriers
30. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
31. Regional specificity of brain atrophy in Huntington's disease
32. Odor detection, learning, and memory in Huntington's disease
33. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease
34. Therapeutic opportunities in polyglutamine disease
35. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
36. Unified Huntington's Disease Rating Scale: Reliability and consistency
37. Statements from the Vancouver group
38. Guidelines for the molecular genetics predictive test in Huntington's disease
39. 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
40. Dramatic mutation instability in HD mouse striatum: Does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
41. Subtle changes among presymptomatic carriers of the Huntington's disease gene
42. The nucleus pontis centralis caudalis in Huntington's disease
43. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes
44. Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial
45. 18FDG and computed tomographic scan
46. Morphometric studies of the neuropathological changes in choreatic diseases
47. Ocular motor abnormalities in Huntington's disease
48. Executive and mnemonic functions in early Huntington's disease
49. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease
50. Visual object and visuospatial cognition in Huntington's disease: Implications for information processing in corticostriatal circuits
51. Abnormal ocular motor control in Huntington's disease
52. Brainstem findings in Huntington's disease. Possible mechanisms for slow vertical saccades
53. Dorsal cortical regions subserving visually guided saccades in humans: An fMRI study
54. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease
55. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease
56. Huntington's disease: Neurological assessment of potential gene carriers presenting for predictive DNA testing
57. Reduced penetrance of the Huntington's disease mutation
58. Mechanisms underlying neural cell death in neurodegenerative diseases: Alterations of a developmentally-mediated cellular rheostat
59. Olfactory function in Huntington's disease patients and at-risk offspring
60. A differential neural response in the human amygdala to fearful and happy facial expressions
61. Location of the human posterior eye field with functional magnetic resonance imaging
62. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease
63. Recent advances on the pathogenesis of Huntington's disease
64. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood
65. A specific neural substrate for perceiving facial expressions of disgust
66. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease
67. Differential loss of striatal projection neurons in Huntington's disease
68. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex
69. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease gene reveals Huntingdon disease cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats
70. Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease
71. Loss of disgust. Perception of faces and emotions in Huntington's disease
72. Delaying the onset of Huntington's in mice
73. Huntington disease
74. Neuropathological classification of Huntington's disease
75. Impaired planning but intact decision making in early Huntington's disease: Implications for specific fronto-striatal pathology
76. Gender effects on age-related changes in brain structure
77. Pathology of CAG repeat diseases
78. Locus coeruleus involvement in Huntington's disease